Cuties

Lefamulin Receives Approval in Taiwan for Treatment of Community-Acquired Pneumonia

Retrieved on: 
Wednesday, September 8, 2021

The anticipated launch timing of XENLETA in Taiwan is undecided.

Key Points: 
  • The anticipated launch timing of XENLETA in Taiwan is undecided.
  • Nabriva Therapeutics is a biopharmaceutical company engaged in the commercialization and development of innovative anti-infective agents to treat serious infections.
  • Nabriva Therapeutics received U.S. Food and Drug Administration approval for XENLETA (lefamulin injection, lefamulin tablets), the first systemic pleuromutilin antibiotic for community-acquired bacterial pneumonia (CABP).
  • These forward-looking statements should not be relied upon as representing Nabriva Therapeutics views as of any date subsequent to the date of this press release.

First Quality Donates Half a Million Cuties® Diapers to Good+Foundation

Retrieved on: 
Tuesday, March 30, 2021
Clothing, Babycare, Consumer goods, Children's clothing, Diaper, Hygiene, Infancy, Undergarments, Depend, Cuties

GREAT NECK, N.Y., March 30, 2021 /PRNewswire/ --To help families in need of diapers during the pandemic, First Quality Consumer Products, LLC donated 500,000 Cuties diapers to Good+Foundation in 2020.

Key Points: 
  • GREAT NECK, N.Y., March 30, 2021 /PRNewswire/ --To help families in need of diapers during the pandemic, First Quality Consumer Products, LLC donated 500,000 Cuties diapers to Good+Foundation in 2020.
  • Now, higher rates of job loss, food insecurity and housing instability mean even more families are struggling to afford diapers.
  • It's an expense that can add up quickly: Children require 6 to 12 diapers per day, depending on their age.
  • To help meet unprecedented community needs, First Quality shipped truckloads of Cuties diapers to the Good+Foundation warehouse in New York City.